Clinical trial · Observational
Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
NCT01466946CI-TRIAL-00020891completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| semi-structured interviews | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- semi-structured interviews
- description
- A qualitative study of MSKCC lung cancer patients of Hispanic/Latino descent by collecting retrospective patient narratives to understand the processes that led them to seek medical help when they did, their experiences in seeking and receiving medical guidance, as well as their decisions regarding lung cancer treatment. In addition, we will explore how these patients' representations of lung cancer with its associated risk factors and symptoms affected their treatment decisions.
- interventionNames
- Behavioral: semi-structured interviews
Primary outcomes (2)
- measure
- psychosocial issues
- timeFrame
- 2 years
- description
- related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
- measure
- cultural issues
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV * 18 years of age or older * Fluent in English or Spanish * Patients must reside in the U.S Exclusion Criteria: * Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)
References
Publications (0)
Data not yet available
No reference posted for this study.